Audible Premium Plus. $0.99/mo for the first 3 months. Get this deal. Cancel anytime.

Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials
May 26 2022
Length: 27 mins
Podcast

Failed to add items

Sorry, we are unable to add the item because your shopping cart is already at capacity.

Add to Cart failed.

Please try again later

Add to Wish List failed.

Please try again later

Remove from wishlist failed.

Please try again later

Adding to library failed

Please try again

Follow podcast failed

Please try again

Unfollow podcast failed

Please try again

Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

Listen for free

View show details

Summary
Overview of olipudase alfa
Efficacy and safety of olipudase alfa from phase 2 and 3 trials
Show more Show less

Show more Show less

What listeners say about Emerging Therapies: Efficacy and Safety Data from Phase 3 Trials

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews

No Reviews are Available

Report a review on Amazon